Eliem Therapeutics Inc. (ELYM)
NASDAQ: ELYM
· Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM
13F Institute Ownership
Total Institutes of 9 in Eliem Therapeutics reduced their positions with a decrease of 66 investors compared to the previous quarter. A reduction of 20.37M shares, as total invested capital declined by $56.94M with ownership percentage dropping from 182.20% to 115.07%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 103.52% | 31.42M | +0.00% | 38.33M | 0.64% | May 15, 2025 |
| Kynam Capital Management, LP | 3.45% | 1.05M | +91.41% | 1.28M | 0.11% | May 15, 2025 |
| Deep Track Capital, LP | 3.43% | 1.04M | +0.00% | 1.27M | 0.04% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.